澳门威斯尼斯人网址44(欢迎您)

科学研究

    Laurence Zitvogel

     

    Address          114 Rue Edouard Vaillant 

                             94800 Villejuif, France


 

 

 

 

 

Current Positions

2016– Director, Torino-Lumiere, Program Project, Paris, France

2011– Member of Co-Directorate, Gustave Roussy Cancer Campus, Villejuif, France

2003– Full Professor, Immunology & Biology, Kremlin Bicêtre School of Medicine, University Paris XI

2002– Co-Director, Center of Clinical Investigations in Biotherapies of Cancer, GRCC-Curie, Paris

2000– Director, Laboratory “Tumor immunology and immunotherapy” INSERM U1015, GRCC

1998– Hospital Practioner, Breast Cancer Department, Clinical attending, GRCC

 

Previous Positions

1995-2000 Associate Professor, Clinical attending, Medical University of Paris XI, Villejuif

1995-1998 Post-doctoral fellowship, Adenovirus Gene Therapy, Pr Pericaudet’s lab, Villejuif, France

1994-1995 Assistant Professor, University of Pittsburgh, Pittsburgh Cancer Institute, USA

1992-1994 Instructor, University of Pittsburgh, Pittsburgh Cancer Institute, USA

1990 Master in Tumor Immunology, Prof. Fridman’s lab. Institut Curie, Paris

 

Education

1987 MD, School of Medicine, Pitié Salpétrière, University of Paris VI, France

1992 Board Certificate, Medical Oncology, University Paris VII, France

1995 PhD, Immunology, University Paris VII, France - Pittsburgh Cancer Institute, Pittsburg, PA, USA

1998 Habilitation, University Paris XI, France

 

Fellowships and Awards

2014 Swiss Bridge Award for Cancer Research, Switzerland

2013 Ligue Française contre le Cancer, Research Prize, Conseil Général des Yvelines, Versailles

2012 Member of the National Academy of Medicine, Biology Division, Paris, France

2012 Permanent member of the European Academy of Cancer Sciences, ECCO

2011 Medical Research Prize, Price Raymond Rosen Fondation pour la recherché médicale, France

2007 INSERM Prize for Translational Research, French Medical Research Council (INSERM)

2007 Gallet & Breton Prize, National Academy of Medicine, Paris, France

2005 Charles Oberling Prize, Senate of the French Republic, Paris, France

2000 Gustave Roussy Prize, National Academy of Sciences, Paris, France

1999 Prize of the Chancellery, University of Paris City Hall Paris

1996 Ligue Françise contre le Cancer, Research Prize,Conseil Général Haute Loire, France

1995 Merit Award, Society for Biological Therapy, Nappa Valley, CA, USA

1994 Presidential Award, American Society of Clinical Oncology, LA, CA, USA

1992 Vocation Prize, Bleustein Blanchet Foundation, Paris, France

1992 Gold Medal, Internal Medicine, first Prize, Assistance Publique-Hôitaux de Paris

 

Principal Commissions of Trust

2016– Scientific Advisory Board (SAB), Transgene, Paris-Illkirch, France

2015– SAB, Lytix Ltd., Oslo, Norway

2015– SAB, NeoVacs, Paris, France

2015– SAB, GSK, Philadelphia, PA, USA

2014– Board of Directors/Executive Board, Transgene, Paris, France

2014– Board of Directors/Executive Board, National Institute of Cancer (INCA), Paris

2011-2014 SAB, DKFZ, Heidelberg, Germany

2011 Helmoltz Foundation, research committee

2001-2003 French Medical Research Council (INSERM)

1997 EORTC, Immunology Scientific Commitee

 

Organization of Scientific Meetings

2017 Organizing comittee, AACR Conference, Washington DC, DC, USA

2016 Organizing comittee, Cold Spring Harbor Suzhou, China

2015-2016 Organizing comittee, AACR/CIMT/CRI/EATI Conf. Tumor Immunology NYC, USA

2013 Co-Organizer, Keystone Symposium, Vancouver, British Columbia, Canada

2013 Coordinator, Cancéropôle Ile-de-France, Microbiota Conf, Paris, France

2011 Co-Organizer, Keystone Symposium, Santa Fe, New Mexico, USA

2006-2016 President and co-organizer, Miltenyi Immunology Annual Conferences, Paris, France

2015 Organizing comittee, AACR Conference on Tumor Immunology, San Diego, CA, USA

2013 Organizing comittee, ECDO Conference, Paris, France

 

Principal Editorial Activities

2012– Editor-in-Chief, OncoImmunology (Landes Bioscience), Austin, Texas, USA

2010-2016 Editor (Immunology), Cell Death & Disease (Nature Publishing Group), London, UK

2005-2012 Associate Editor, Cancer Research (AACR), Philadelphia, PA, USA

 

Guest Editor

2016 J. Clinical Investigations (series on exosomes biology)

2008 Current Opinion in Immunology (Springer)

2008 Cell Death Differentiation (Nature Publishing Group)

2007 Immunological Reviews (Munksgaard-Springer)

 

Major Collaborations

Together with some hundreds of collaborators/co-authors,our team has published close to 360 PubMed-indexed papers(search Zitvogel_L). The most important collaborative efforts include G. Kroemer from Les Cordeliers, University Paris Descartes (230 common publications) on the immunogenic cell death concept (together with Dr D. Green, St. Judes Hospital in Memphis, Dr M. Pittet, Harvard Medical School), Mark J. Smyth from QIMR Berghofer Medical Research Institute in Australia (>20), the Dendritic cell team (Dr Miriam Merad, Mont Sinai, NYC, USA, Dr Florent Ginhoux, A*Star, Singapoor, Dr Federica Sallusto, Bellinzona, Switzerland, Dr Dhodapkar, University of Yale, Connecticut, USA) the Microbiota team (Dr Ivo Gomperts Boneca, G. Eberl, and Dr Mathias Chamaillard, Institut Pasteur, Lille and Paris, France, Dr Joel Doré and Dr P. Lepage, Metagenopolis, INRA, Jouy-en-Josas, France), the Clinical team for breast cancer and melanoma (Dr F. André, Dr S. Delaloge, Gustave Roussy Cancer Center, Dr D. Jaeger, DKFZ, Heidelberg, Germany, Dr J. Wolchock, MSKCC, NYC, USA, Dr M. Maio, University of Siena, Italy, Dr B. Weide University of Tübingen, Germany), and the exosome team (Dr S. Amigorena, INSERM, Institut Curie, Dr Clotilde Théry, Institut Curie, Dr O. Lantz, Institut Curie).